Fluorescence in situ hybridization (FISH) using non-commercial probes in the diagnosis of clinically suspected microdeletion syndromes

Indian Journal of Medical Research

Volumn 138, Issue JUL 2013, 2013, Pages 135-142

  Halder, Ashutosh ^a   Jain, Manish ^a   Chaudhary, Isha ^a   Gupta, Neerja ^a   Kabra, Madhulika ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Fluorescence in situ hybridization; Molecular cytogenetics; Suspected microdeletion syndrome

Indexed keywords

PHYTOHEMAGGLUTININ;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHILD; CHROMOSOME DELETION; CLINICAL TRIAL; CYTOGENETICS; DIGEORGE SYNDROME; DNA NICK TRANSLATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SCREENING; HAPPY PUPPET SYNDROME; HUMAN; HUMAN CELL; INTERPHASE; MAJOR CLINICAL STUDY; MALE; METAPHASE; MICRODELETION SYNDROME; NUCLEIC ACID PROBE; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD;

CHROMOSOME DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MOLECULAR PROBES;

EID: 84881053997     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hunter AG. Outcome of the routine assessment of patients with mental retardation in a genetics clinic. Am J Med Genet 2000; 90: 60-8.
2. Kirchhoff M, Bisgaard AM, Bryndorf T, Gerdes T. MLPA analysis for a panel of syndromes with mental retardation reveals imbalances in 5.8% of patients with mental retardation and dysmorphic features, including duplications of the Sotos syndrome and Williams-Beuren syndrome regions. Eur J Med Genet 2007; 50: 33-42.
3. Flint J, Wilkie AO, Buckle VJ, Winter RM, Holland AJ, McDermid HE. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet 1995; 9: 132-40.
4. Vissers LE, De Vries BB, Osoegawa K, Janssen IM, Feuth T, Choy CO, et al. Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 2003; 73: 1261-70.
5. Brewer CM, Morrison N, Tolmie JL. Clinical and molecular cytogenetic (FISH) diagnosis of Williams syndrome. Arch Dis Child 1996; 74: 59-61.
6. Promkan M, Teingtat S, Stheinkijkarnchai A, Wasant P, Patmasiriwat P. Highest accuracy of combined consensus clinical criteria and SNRPN gene molecular markers in diagnosis of Prader-Willi syndrome in Thai patients. Clin Chem Lab Med 2007; 45: 972-80.
7. Halder A, Jain M, Chaudhary I, Kabra M. Prevalence of 22q11.2 microdeletion in 121 patients with cardiac malformation. BMC Med Genet 2010; 11: 101.
8. Halder A, Jain M, Kabra M, Gupta N. Mosaic 22q11.2 microdeletion syndrome: diagnosis and clinical manifestations of two cases. Mol Cytogenet 2008; 1: 18.
9. Qin YF, Yang JB, Xie CH, Shao J, Zhao ZY. Study on clinical features and fluorescence in situ hybridization detections of 22q11 microdeletion syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007; 24: 284-7.
10. Koshiyama DB, Rosa RF, Zen PR, Pereira VL, Graziadio C, Cóser VM, et al. 22q11.2 deletion syndrome: importance of clinical evaluation and FISH analysis. Rev Assoc Med Bras 2009; 55: 442-6.
11. Veltman JA, Brunner HG. Understanding variable expressivity in microdeletion syndromes. Nat Genet 2010; 42: 192-3.
12. Halder A, Fauzdar A, Kabra M, Saxena A. Detection of 22q11.2 hemizygous deletion by interphase FISH in a patient with features of CATCH22 Syndrome. Indian Pediatr 2005; 42: 1236-9.
13. Chaddha V, Agarwal S, Phadke SR, Halder A. Low level of mosaicism in atypical Prader Willi syndrome: Detection using fluorescent in situ hybridization. Indian Pediatr 2003; 40: 166-8.
14. Halder A, Jain M, Chaudhary I, Varma B. Monozygotic twins with chromosome 22q11.2 microdeletion and discordant phenotype: an investigation for underlying mechanism. Mol Cytogenet 2012; 5: 1-8.
15. Cho EH, Park BY, Cho JH, Kang YS. Comparing two diagnostic laboratory tests for several microdeletions causing mental retardation syndromes: multiplex ligation-dependent amplification vs fluorescent in situ hybridization. Korean J Lab Med 2009; 29: 71-6.
16. Wilson RD, Blight C, Langlois S. Diagnosing chromosomal abnormalities from "big" to "small" with molecular cytogenetic technology. J Obstet Gynaecol Can 2009; 31: 414-21.
17. Kriek M, Knijnenburg J, White SJ, Rosenberg C, den Dunnen JT, van Ommen GJ, et al. Diagnosis of genetic abnormalities in developmentally delayed patients: a new strategy combining MLPA and array-CGH. Am J Med Genet A 2007; 143: 610-4.
18. Wincent J, Anderlid B-M, Lagerberg M, Nordenskjöld M, Schoumans J. High-resolution molecular karyotyping in patients with developmental delay and/or multiple congenital anomalies in a clinical setting. Clin Genet 2011; 79: 147-57.
19. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749-64.